Platelet-activating factor (PAF) receptor as a promising target for cancer cell repopulation after radiotherapy

about

Resolvins suppress tumor growth and enhance cancer therapy.Modulation of Tumor-Associated Macrophages (TAM) Phenotype by Platelet-Activating Factor (PAF) Receptor.Platelet-Activating Factor Receptor Ligands Protect Tumor Cells from Radiation-Induced Cell Death.

P2860

Q47225724-56EEA2C1-942E-4A00-8ABD-8EC714B33AB2 Q49636083-F7196094-8535-4D91-A85B-E59915B0E3DC Q49829026-29D60C89-718B-475D-A0AB-1F1CCEE0E410

P2860

Platelet-activating factor (PAF) receptor as a promising target for cancer cell repopulation after radiotherapy

Item

http://www.wikidata.org/entity/Q37627449

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Platelet-activating factor (PA ...... epopulation after radiotherapy

@en

Platelet-activating factor

@nl

type

Item

label

Platelet-activating factor (PA ...... epopulation after radiotherapy

@en

Platelet-activating factor

@nl

prefLabel

Platelet-activating factor (PA ...... epopulation after radiotherapy

@en

Platelet-activating factor

@nl

P1476

Platelet-activating factor (PA ...... epopulation after radiotherapy

@en

P2093

A P Lepique

http://www.w3.org/2001/XMLSchema#string

I A da Silva

http://www.w3.org/2001/XMLSchema#string

R Chammas

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy.

Platelet activating factor blocks interkinetic nuclear migration in retinal progenitors through an arrest of the cell cycle at the S/G2 transition.

Systemic Platelet-activating Factor Receptor Activation Augments Experimental Lung Tumor Growth and Metastasis

Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences.

Topical photodynamic therapy induces systemic immunosuppression via generation of platelet-activating factor receptor ligands.

Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy.

Expression of the platelet-activating factor receptor enhances benzyl isothiocyanate-induced apoptosis in murine and human melanoma cells

PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis.

P2888

oncsis.2016.90

P304

e296

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONCSIS.2016.90

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sonia Jancar

P577

2017-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28134937

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

5294253

http://www.w3.org/2001/XMLSchema#string

Platelet-activating factor (PAF) receptor as a promising target for cancer cell repopulation after radiotherapy

about

P2860

P2860

Platelet-activating factor (PAF) receptor as a promising target for cancer cell repopulation after radiotherapy

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932